Founded in 2015, Edesa Biotech brings innovative new treatments for dermatological and anorectal diseases. Late-stage prescription drugs developed by Edesa Biotech aim to help patients who experience limited treatment options. Edesa Biotech's focus on dermatology is led by an experienced team that have licensed global rights to clinical stage assets for dermatology and anorectal indications.